EG12762A - Process for preparing of anti-ulger agent of 5-m tolyloxyuracil - Google Patents

Process for preparing of anti-ulger agent of 5-m tolyloxyuracil

Info

Publication number
EG12762A
EG12762A EG418/77A EG41877A EG12762A EG 12762 A EG12762 A EG 12762A EG 418/77 A EG418/77 A EG 418/77A EG 41877 A EG41877 A EG 41877A EG 12762 A EG12762 A EG 12762A
Authority
EG
Egypt
Prior art keywords
ulger
tolyloxyuracil
preparing
agent
ulger agent
Prior art date
Application number
EG418/77A
Other languages
English (en)
Inventor
C Lipinski
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of EG12762A publication Critical patent/EG12762A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60Three or more oxygen or sulfur atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
EG418/77A 1976-07-16 1977-07-13 Process for preparing of anti-ulger agent of 5-m tolyloxyuracil EG12762A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/706,123 US4080454A (en) 1976-07-16 1976-07-16 5-M-Tolyloxyuracil, anti-ulcer agent

Publications (1)

Publication Number Publication Date
EG12762A true EG12762A (en) 1979-12-31

Family

ID=24836300

Family Applications (1)

Application Number Title Priority Date Filing Date
EG418/77A EG12762A (en) 1976-07-16 1977-07-13 Process for preparing of anti-ulger agent of 5-m tolyloxyuracil

Country Status (29)

Country Link
US (1) US4080454A (pt)
JP (1) JPS5337673A (pt)
AR (1) AR213652A1 (pt)
AT (1) AT351561B (pt)
BE (1) BE856710A (pt)
CA (1) CA1061788A (pt)
CH (1) CH622512A5 (pt)
CS (1) CS212264B2 (pt)
DD (1) DD131556A5 (pt)
DE (1) DE2731736A1 (pt)
DK (1) DK139029B (pt)
EG (1) EG12762A (pt)
ES (1) ES460686A1 (pt)
FI (1) FI772183A (pt)
FR (1) FR2358399A1 (pt)
GB (1) GB1542178A (pt)
GR (1) GR68686B (pt)
HU (1) HU177713B (pt)
IL (1) IL52409A (pt)
LU (1) LU77764A1 (pt)
NL (1) NL7707729A (pt)
NO (1) NO772489L (pt)
PH (1) PH13190A (pt)
PL (1) PL103783B1 (pt)
PT (1) PT66808B (pt)
SE (1) SE421125B (pt)
SU (1) SU673169A3 (pt)
YU (1) YU171677A (pt)
ZA (1) ZA773927B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS55158095A (en) * 1979-05-25 1980-12-09 Zenkosha Tokei Kk Controller for washing machine
JPS5822406U (ja) * 1981-08-04 1983-02-12 トキコ株式会社 消音器
US7776870B2 (en) 2005-08-22 2010-08-17 Melior Pharmaceuticals I, Inc. Methods for modulating Lyn kinase activity and treating related disorders
CA2678813A1 (en) * 2007-02-20 2008-08-28 Melior Pharmaceuticals I, Inc. Methods of identifying activators of lyn kinase
CA2693809A1 (en) * 2007-07-23 2009-01-29 Melior Discovery, Inc. Methods of activating irs-1 and akt
US8552184B2 (en) * 2008-07-03 2013-10-08 Melior Pharmaceuticals I, Inc. Compounds and methods for treating disorders related to glucose metabolism
WO2011150300A1 (en) * 2010-05-28 2011-12-01 Melior Pharmaceuticals I, Inc. Prevention of pancreatic beta cell degeneration
BR112019021140A2 (pt) 2017-04-10 2020-05-19 Univ Louisiana State composição, método para reduzir os níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento, método de indução do bege de adipócitos ou prevenção da degeneração das células beta do pâncreas, e, ativador de lyn cinase e agonista de trpm8 para uso na redução dos níveis de glicose no sangue, ganho de peso ou níveis de depósito de gordura, ou tratamento.
WO2019164799A1 (en) 2018-02-21 2019-08-29 Melior Pharmaceuticals I, Inc. Treatment of liver diseases

Also Published As

Publication number Publication date
HU177713B (en) 1981-12-28
PL103783B1 (pl) 1979-07-31
GR68686B (pt) 1982-02-01
ES460686A1 (es) 1978-12-01
FR2358399B1 (pt) 1980-10-17
DK139029C (pt) 1979-05-07
CS212264B2 (en) 1982-03-26
PH13190A (en) 1980-01-16
LU77764A1 (pt) 1978-02-02
BE856710A (fr) 1978-01-11
FI772183A (pt) 1978-01-17
US4080454A (en) 1978-03-21
AR213652A1 (es) 1979-02-28
JPS5337673A (en) 1978-04-06
CH622512A5 (pt) 1981-04-15
SU673169A3 (ru) 1979-07-05
DK318177A (pt) 1978-01-17
SE421125B (sv) 1981-11-30
GB1542178A (en) 1979-03-14
JPS5512017B2 (pt) 1980-03-29
DE2731736A1 (de) 1978-01-26
CA1061788A (en) 1979-09-04
ZA773927B (en) 1978-05-30
AU2663877A (en) 1978-05-18
NO772489L (no) 1978-01-17
PL199633A1 (pl) 1978-04-10
ATA509277A (de) 1979-01-15
IL52409A0 (en) 1977-08-31
PT66808A (en) 1977-08-01
AT351561B (de) 1979-08-10
YU171677A (en) 1982-06-30
DD131556A5 (de) 1978-07-05
PT66808B (en) 1978-12-21
DK139029B (da) 1978-12-04
IL52409A (en) 1979-11-30
NL7707729A (nl) 1978-01-18
SE7707471L (sv) 1978-01-17
FR2358399A1 (fr) 1978-02-10

Similar Documents

Publication Publication Date Title
JPS5331604A (en) Process for preparing metalacids of organicacid
HU177716B (en) Process for preparing derivatives of spiro-hydantoin
EG12406A (en) Process for preparing of novel n-aryl-n-(1-l-4-piperidinyl)-arylacetamides
JPS52110775A (en) Process for manufacture of fiberrretnforced foam
JPS52109581A (en) Process for enhancing waterrabsorptivity of celluloseecontaining substance
EG14072A (en) Process for preparing of meta-aryloxy-benzaldehydes
GB1523529A (en) Process for the preparation of tetrazole - 5 - carboxamides
EG13080A (en) Process for preparing of gamma-pyrones
PT66498B (en) Process for preparation of new n-phosphonomethylglicine derivatives
EG12762A (en) Process for preparing of anti-ulger agent of 5-m tolyloxyuracil
PH12481A (en) Process for preparation of 3-halomethylcephens
GR63697B (en) Process for derivatives preparation of phenyl-alamine
GR63658B (en) Process for derivatives preparation of naphyridine
EG13191A (en) Process for preparing of quinoxaline-di-n-oxide derivatives
CH609341A5 (en) Process for the preparation of 5-methylisoxazole- 4-carboxanilides
CS190339B2 (en) Process for preparing derivatives of sulphonyl-benzimidazole
JPS5285145A (en) Process for manufacture of 22halocyclobutanone
PT67465B (en) Process for preparing of haloacylamides
ZA77714B (en) Process for preparation of 7-alkoxy-3-chloromethylcephems
GR63624B (en) Process for preparation of new aryl-alkylamine
ZA773011B (en) Process for the preparation of 2-aryliminothiazoline solutions
CS192475B2 (en) Process for preparing derivatives of triphenylalkene
IL51653A (en) Process for preparation of 3-hydroxymethylcephems
EG12776A (en) Process for preparing of zearalin ethers
EG12921A (en) Process for preparing of m-phenoxybenzamide derivatives